Pacific Biosciences of California, Inc. Long-Term Debt, Maturity, Remainder of Fiscal Year
Pacific Biosciences of California, Inc. (PACB) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $353.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2019-11-07
- 2019-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $353.00K.
- 2019-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $702.00K.
- 2019-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $1.05M.
- 2014-12-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $28.98M.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2019-09-30 | $353.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $702.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $1.05M 10-Q · filed 2019-05-03 |
| 2014-12-31 | $28.98M 10-K · filed 2015-03-12 |
| 2013-12-31 | $30.77M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |